Enliven Therapeutics
ELVN
#5266
Rank
A$1.88 B
Marketcap
$38.59
Share price
3.48%
Change (1 day)
120.96%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$26.94 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are A$26.94 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$38.1 M-83.81%
2022-12-31A$0.23 B9.2%
2021-12-31A$0.21 B9.5%
2020-12-31A$0.19 B